Genus plc (GNS.L)
Sells improved pig and cattle genetics to farmers worldwide.
2,218.00-0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-10.9%
The outlook
Genus trades at 2218p with a strong analyst consensus of Buy across 12 firms. The stock sits near the upper end of its 52-week range, though price momentum versus moving averages appears mixed. Analysts' average price target implies approximately 39% upside from current levels.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 12 analysts
Price trendMixed vs its moving averages
52-week range69% of the way from its 52-week low to high
Price targetAvg target +39% vs current price
Analyst price target
~12-month · 12 analysts3,087.33average target+39.2% vs now
Now 2,218.00
Low 2,260.00High 3,700.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.47B
52-wk high
3,228.80
52-wk low
0.00
50-day avg
2,211.48
200-day avg
2,522.09
Trailing P/E
31.2